Xeris Biopharma (NasdaqGS:XERS) Q3 2026 Earnings call November 05, 2026 08:30 AM ET Company ParticipantsCristi Barnett - VP of Investor RelationsJohn Shannon - CEO and ChairmanSteve Pieper - CFOConference Call ParticipantsRoanna Ruiz - AnalystDavid Amsellem - AnalystNone - AnalystNone - AnalystChase Knickerbocker - AnalystOperatorHello, everyone. Thank you for joining us, and welcome to Xeris Biopharma Third Quarter 2026 earnings conference call. After today's prepared remarks, we will host a question-and-a ...